---
title: "European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/272443535.md"
description: "European equities traded in the US saw a slight increase in American depositary receipts, rising 0.17% to 1,746.17 on the S&P Europe Select ADR Index. Notable gainers included Natuzzi (+12%) and BioNTech (+3.7%), while DBV Technologies (-3.2%) and Opera (-2%) were among the decliners. From the UK and Ireland, NuCana (+8.8%) and BHP Group (+2.5%) led the gains, whereas Autolus Therapeutics (-8.2%) and Smith & Nephew (-4.7%) faced declines. MT Newswires does not provide investment advice."
datetime: "2026-01-13T16:10:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/272443535.md)
  - [en](https://longbridge.com/en/news/272443535.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/272443535.md)
---

# European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading

11:10 AM EST, 01/13/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were heading slightly higher late Tuesday morning, rising 0.17% to 1,746.17 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by furniture manufacturer Natuzzi (NTZ) and biotech firm BioNTech (BNTX), which advanced 12% and 3.7% respectively. They were followed by petroleum refiner Equinor ( EQNR ) and biopharmaceutical company argenx (ARGX), which increased 3.1% and 1.6% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies ( DBVT ) and internet browser company Opera (OPRA), which dropped 3.2% and 2% respectively. They were followed by biopharmaceutical company Cellectis ( CLLS ) and medical device maker EDAP TMS ( EDAP ) , which fell 1.2% and 1% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company NuCana ( NCNA ) and mining company BHP Group ( BHP ) , which rose 8.8% and 2.5% respectively. They were followed by biopharmaceutical company Akari Therapeutics ( AKTX ) and oil and gas company Shell (SHEL), which were up 2.3% each.

The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics ( AUTL ) and medical equipment company Smith & Nephew ( SNN ) , which lost 8.2% and 4.7% respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and software company Endava ( DAVA ) , which were down 4.4% and 3% respectively.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [DBVT.US](https://longbridge.com/en/quote/DBVT.US.md)
- [BNTX.US](https://longbridge.com/en/quote/BNTX.US.md)
- [NCNA.US](https://longbridge.com/en/quote/NCNA.US.md)
- [AUTL.US](https://longbridge.com/en/quote/AUTL.US.md)

## Related News & Research

- [BioNTech Maps Oncology Push, $1B Buyback and Manufacturing Cuts at AGM](https://longbridge.com/en/news/286592399.md)
- [Duality Biotherapeutics Exercises U.S. Cost and Profit-Sharing Option for BioNTech ADC](https://longbridge.com/en/news/286169551.md)
- [Germany says vaccine supply secure despite BioNTech production loss](https://longbridge.com/en/news/285369696.md)
- [Sierk Poetting Sells 50,000 Shares of BioNTech (NASDAQ:BNTX) Stock](https://longbridge.com/en/news/283899032.md)
- [Goldman Sachs Sticks to Their Buy Rating for Autolus Therapeutics (AUTL)](https://longbridge.com/en/news/286522682.md)